AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
Sep 3, 2021
30786_dirs_2021-09-03_9a818541-64bf-4862-98e3-5b014fc4f36f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-01
Reporting Person: WRIGHT DARA (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Bio-Rad A Common Stock | M | 433 | — | Acquired | 761.000 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | F | 150 | $825.77 | Disposed | 611.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | Restricted Stock Units | $0 | A | 1621 | Acquired | Bio-Rad A Common Stock (1621) | Direct | |
| 2021-09-01 | Non-Qualified Stock Option (right to buy) | $814.95 | A | 1621 | Acquired | 2031-09-01 | Bio-Rad A Common Stock (1621) | Direct |
| 2021-09-02 | Restricted Stock Units | $0 | M | 433 | Disposed | Bio-Rad A Common Stock (433) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
F5: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.